When scientists led by Diane Mathis at Harvard Medical School in Boston depleted meningeal Tregs in mice, those other immune cells sprang to action, churning out cytokines and infiltrating the brain ...

Scientists of the University Medical Center Göttingen (UMG) have identified new interactions between pancreatic cancer cells ...

Autolus Therapeutics' obe-cel, branded Aucatzyl, is the first CAR-T therapy approved without a REMS, highlighting its safety and unique mechanism.

The international consulting firm Clarivate makes its bet among the novelties ready for the medicine cabinet this year: three ...

Scientists have uncovered a mechanism for reinvigorating the immune system to stop it from flagging when it’s fighting ...

A new study shows how an anticancer drug triggers an 'outside in' signal that gets it sucked into a cancer cell. The work reveals a new signaling mechanism that could be exploited for delivering other ...

Priya Hays, Hays Documentation Specialists, discusses innovations and advancements in the development of personalized cancer ...

A group of 18 colorectal cancer patients experienced complete remission after taking the experimental drug dostarlimab for ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

HCW Biologics (HCWB) announced that it has received clearance of its Investigational New Drug Application, IND, from the U.S. Food and Drug ...

The total consideration to acquire 100 percent of the issued share capital by Biotheus amounts to $800 million, predominantly in cash, with a small portion in BioNTech American Depositary Shares, plus ...

New research pinpoints 298 parts of the genome associated with higher risk of bipolar disorder. This could lead to better ...